Halsin serves innovation makers, those who go beyond medical and scientific discoveries to where innovation adds life-changing value.
■ EXAMPLES OF OUR WORK ■
Product Communications:
Product Launch
Sometimes medical advances are relatively straight forward. Moximed’s KineSpring works like a shock absorber in the knee to treat osteoarthritis pain. Halsin launched KineSpring in several EU countries targeting both the medical community and potential patients.
Corporate Communications:
Strategic Counsel
There is much for patients to celebrate when a life saving or life changing treatment becomes available. Perhaps even more significant is when a completely new paradigm is introduced. uniQure’s Glybera became the first gene therapy approved in Europe. Halsin provided communications throughout the approval process.
Media Relations:
Clinical Trial Recruitment
A cure for Parkinson’s disease is the goal. To get there, drugs need to be developed and clinical studies conducted. The Michael J Fox Foundation came to Halsin to coordinate the European launch of Fox Trial Finder, an online tool to match volunteers to clinical studies.
■ WHO WE ARE ■
Halsin Partners provides communication solutions for the unique business challenges faced by the life science industry – from start up biotech to multi-billion market cap companies.
Exclusively Life Sciences
Translate complex scientific concepts to various target audiences
Communicators of Seminal Firsts
Communicators of Seminal Firsts
1st German biotech IPO
1st Gene therapy approval
1st Dual US/EU listing
1st RNAi merger
Scalable Network
US and EU feet on the ground with local insight and knowledge of “ways of doing things”
■ MEET THE TEAM ■
Our client service model centers around providing the best team for each project. Whether it’s the launch of a medical device in five European countries or an event at a US scientific conference, we have the right team to ensure success. Our team members are senior consultants and experts in their fields. Each in-country consultant provides the local knowledge on the mood of the industry, the insights and particularities of the media and a sense of “how things work” on the ground.
■ WHAT OUR CLIENTS SAY ■
MDxHealth values Halsin Partners’ professionalism and responsiveness. You are always available, regardless of the time zone, offering good and valuable advice. Halsin has the knowledge and network to fast track company and product awareness.
Jan Groen, Chief Executive Officer, MDxHealth
The professionalism of Halsin towards public and investor relations is far beyond the norm, in particular your ‘can do’ service attitude makes you an ideal extension of our internal efforts.
Roland Sackers Chief Financial Officer, QIAGEN
The Halsin team has consistently demonstrated professionalism and patience throughout the time we have worked together. As a start-up company with limited resources, we value Halsin’s ability to think about longer term strategic issues and to provide on-site tactical support to help deliver a successful outcome. Halsin’s efforts have helped us gain significant, measurable patient awareness of our product.
Keith Fong, Director of Marketing, Moximed
We worked with Halsin to communicate our partnership with Servier. The resulting media coverage was really impressive and will definitely help GeNeuro move forward.
Christophe Guichard, Chief Financial Officer, GeNeuro
Halsin stands for high performance in public and investor relations, with the team coping particularly well under tremendous time pressures. For me, high performance means precision, and a good mix of strategic advice and successful execution through a powerful personal network.
Joern Aldag, Chief Executive Officer, UniQure
Halsin seems tireless in hunting down opportunities to profile New Zealand companies and capabilities. Your knowledge of European biotech media is invaluable. Even though you are a separate company to NZTE, I really feel that you are part of ‘the family’. I value your professional input.
Georgina Langdale, Marketing & Communications Manager, New Zealand Trade & Enterprise
I wanted to take this opportunity to send you a short note to thank you for your support in putting JADO on the map and significantly changing the face of the company.
Charl van Zyl, Chief Executive Officer, JADO Technologies GmbH
You are an OUTSTANDING team and I am so lucky to have you all aligned with Concert. I greatly appreciate all your efforts to make our media pitch a success. We have received a tremendous amount of coverage and the team here couldn’t be more pleased.
Justine E. Koenigsberg Senior Director, Corporate Communications and Investor Relations, Concert Pharmaceuticals, Inc.
Contact:
If you are interested in finding out more about the communications services we offer, contact us on info@halsin.com
Location:
96 Kensington High Street
London
W8 4SG, UK